Interacting Drugs |
Lansoprazole, amoxicillin, and clarithromycin vs Vemurafenib |
Security Level |
|
Mechanism |
Vemurafenib: CYP3A4 Inhibitors (Strong) may increase the serum concentration of Vemurafenib. |
Management |
Monitor therapy |
Lansoprazole, amoxicillin, and clarithromycin vs Vemurafenib
Post Review about Lansoprazole, amoxicillin, and clarithromycin vs Vemurafenib Click here to cancel reply.
Other Interactions of Lansoprazole, amoxicillin, and clarithromycin
Other Interactions of Vemurafenib
Lansoprazole, amoxicillin, and clarithromycin vs Vemurafenib
Interacting Drugs |
Lansoprazole, amoxicillin, and clarithromycin vs Vemurafenib |
Security Level |
|
Mechanism |
Vemurafenib: QTc-Prolonging Agents may enhance the QTc-prolonging effect of Vemurafenib. |
Management |
Avoid combination |
No comments yet.
Post Review about Lansoprazole, amoxicillin, and clarithromycin vs Vemurafenib Click here to cancel reply.
Other Interactions of Lansoprazole, amoxicillin, and clarithromycin
Other Interactions of Vemurafenib
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.